Two New 13-Hydroxylated Milbemycin Metabolites from the Genetically Engineered Strain Streptomyces Avermitilis AVE-H39

Ji-Dong Wang,Huan Qi,Ji Zhang,Jian-Song Li,Shao-Yong Zhang,Zhi-Kui Hao,Li-Qin Zhang,Wen-Sheng Xiang
DOI: https://doi.org/10.1080/10286020.2020.1803294
2020-01-01
Journal of Asian Natural Products Research
Abstract:Two new milbemycin metabolites, 13 alpha-hydroxymilbemycin beta(13)(1) and 26-methyl-13 alpha-hydroxymilbemycin beta(13)(2), were isolated from the fermentation broth of a genetically engineered strainStreptomyces avermitilisAVE-H39. Their structures were determined by the comprehensive spectroscopic data, including 1 D, 2 D NMR, MS spectral analysis and the comparison with data from the literature. Compounds1and2not only exhibited potent acaricidal activities againstTetranychus cinnabarinus, but also had nematocidal activity againstBursaphelenchus xylophilus.
What problem does this paper attempt to address?